References

Acne No More Ebook

Natural Treatment for Acne Found

Get Instant Access

Adams |, Lammer E). Relationship between dysmorphology and neuropsychological functions in children exposed to isotretinoin (in utero). In: T. Fujii, GJ Boer (eds), Functional Neuroteratology of Short Term Exposure to Drugs. Tokyo: Teiko University Press, 1991, pp. 159-68.

Adams ). The adverse effect profile of neurobchavioral teratogens: retinoic acid. Birth Def Res A 2004; 70: 344.

Aidoo A, Gao N, Neft RE el al. Evaluation of the genotoxicity of gentian violet in bacterial and mammalian cell systems. Teratogen Carcinogen Mutagen 1990: 10: 449-62.

Akhavan A, Bcrshad S. Topical acne drugs. Am ) Clin Dermatol 2003; 4: 473-92.

Andersen A. Final amended report on the safety assessment of oxyquinoline and oxyquinolinc sulfate as used in cosmetics. Intl J Toxicol 2006: 25 (Suppl I): 1-9.

Au W, Pathak S, Collie CJ et al. Cytogenetic toxicity of gentian violet and crystal violet on mammalian cells in vitro. Mutat Res 1978: 58: 269-76.

Autret E, Berjot M. Jonville-Bera AP et al. Anophthalmia and agenesis of optic chi asma associated with adapalene gel in early pregnancy. Lancet 1997: 350: 339.

Ballzar B, Ericson A, Kälten B et al. Delivery outcome in women employed in medical occupations in Sweden.) Occup Med 1979; 21: 543-8.

Barbero P, Lotersztein V, Bronberg K et al. Acitretin embryopathy: a case report. Birth Def Res A 2004; 70: 831-3.

Bargman H. Is podophyllin a safe drug to use and can it be used in pregnancy? Arch Dermatol 1988; 124: 1718-20

Bhargava HN, Leonard PA. Triclosan: applications and safety. Am J Infect Control 1996; 24:209-18.

Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation, 7th edn. Baltimore. MD: Williams & Wilkins, 2005.

Camera G. Pregliasco P. Ear malformation in baby bom to mother using tretinoin cream (Letter). Lancet 1992; 339: 687.

Carlier P. Choulika S, Dally S. Topical retinoids exposure in pregnancy. Cooperative Study from lanuary 1992 to April 1997: 132 cases and 94 with known pregnancy outcome. Therapie 1998: 53: 180.

Colley S. Walepolc I, Fabian VA et al. Topical tretinoin and fetal malformations. Med J Aust 1998: 168: 467.

Committee on Developmental Toxicology NAS/NRC. Scientific Frontiers in Developmental Toxicology and Risk Assessment, National Research Council. Washington DC, 2000.

Czeizel AE, Kazy Z. Vargha P. Vaginal treatment with povidone-iodine suppositories during pregnancy. Intl J Gynaecol Obstet 2004; 84: 83-5.

de Die-Smulders CEM. Sturkenbuom MCJM, Veraarl | et al. Severe limb defects and craniofacial abnormalities in fetus conceived during acitretinc therapy. Teratology 1995; 52: 215-19.

de Sailtis M, Lucchese A, Carducci B el al. Latanoprost exposure in pregnancy. Am | Ophthalmol 2004; 138: 305-6.

Etnarson A, Costei A, Kalra S et al. The use of topical 5% imiquimod during pregnancy: a case series. Reprod Toxicol 2006; 21: 1-2.

Ellegard EK, Hellgrcn M, Karlsson NG. Fluticasone propionate aqueous nasal spray in pregnancy rhinitis. Clin Otolaryngol 2001; 26: 394-400.

Fölster-Holst R, Rufli T, Christophers E. Treatment of scabies with special consideration of the approach in infancy, pregnancy and while nursing {in German], Hautarzt 2000; 51: 7-13.

Food and Drug Administration. New measures to manage risks associated with accu-tane. ] Am Med Assoc 2001; 283: 1146.

Fransseil ME. van der Wilt GJ. de )ong PC et al. A retrospective study of the teratogenicity of dermatological coal tar products {Letter). Acta Derm Venereol 1999: 79: 390-91.

Garbis H, Elefant E, Bertolotti E et al. Pregnancy outcome after periconceplional and first trimester exposure to methoxsaten photochemotherapy. Arch Dermatol 1993; 131: 492-3.

Geiger JM. Baudin M. Saurat JH. Teratogenic risk with etretinate and aeitretine treatment. Dermatology 1994; 189: 109-16.

Geiger ]M. Walker M. Is there a reproductive safety risk in male patients treated with aeitretine? Dermatology 2002: 205: 105-7.

Gunnarskug IG, Källin B. Lindelof BG et al. Psoralen photochemotherapy (PUVA) and pregnancy. Arch Dermatol 1993: 129: 320-23.

Honein MA. Paulozzi LJ. Accutane a-exposed pregnancies. Teratology 2000; 61: 442.

Honcin MA, Paulozzi LJ, Erickson ID. Continued occurrence of accutane " exposed pregnancies. Teratology 2001; 64: 142-7.

Jick SS, Terris BZ, Jick H. First trimester topical tretinoin Lancet 1993; 341: 1181-2.

Johnson SM, Martinez M, Freedman S. Management of glaucoma in pregnancy and lactation. Survey Ophthalmol 2001; 45: 449-54.

Kiillén BAJ. Otterblad Olaussen P. Maternal drug use in early pregnancy and infant cardiovascular defect. Reprod Toxicol 2003; 17: 255-61.

Karol MD. Conner CS. Watanabe AS et al. Podophyllum: suspected teratogenicity from topical application. Clin Toxicol 1980; 16: 283-6.

Kennedy D. Hurst V. Konradsdottir E et al. Outcome of pregnancy following exposure to permethrin head lice shampoo. Birth Def Res B 2003; 68: 294-5.

Kennedy D. Hurst V, Konradsdottir E el al. Pregnane outcome following exposure to permethrin and use of teratogen information Am | Perinatol 2005: 22: 87-90.

Kimmel CA, Moore W. Stara JF. Hexachlorophene teratogenicity in rats. Lancet 1972;2: 765.

Koepelman JN, Miyazawa K. Inadvertent 5-fluorouracil treatment in early pregnancy: a report of three cases. Reprod Toxicol 1990; 4: 233-5.

Lammer EJ, Chen DT. Hoar RM et al. Retinoic acid embryopathy. N Engl J Med 1985;313:837-41.

Lammer E|. Hayes AM. Schunior A et al, Unusually high risk for adverse outcomes of pregnancy following fetal isotretinoin exposure. Am ] Hum Genet 1988; 43: A58.

Larsen FG. Steinkjer R, |akobsen P et al. Acitretin is converted to etretinate only during concomitant alcohol intake. Br | Dermatol 2000: 143: 1164-9.

Lauwerys R, Bonnier C, Eurard P ct al. Prenatal and early postnatal intoxication by inorganic mercury resulting from maternal use of mercury containing soap. Hum Toxicol 1987; 6; 253-6.

Lee AG, Pless M, Falardeau | el al. The use of acetazolamide in idiopathic intracranial hypertension during pregnancy. Am ] Ophthalmol 2005; 139: 855-9.

Lipson AH. Collins F. Webster WS, Multiple congenital defects associated with maternal use of topical tretinoin. Lancet 1993; 341; 1352-3.

Lockharl |D How toxic is hexachlorophene? Pediatrics 1972: 50: 220-35.

Loureiro KD, Kao KK, Jones KL et al. Minor malformations characteristic of the retinoic acid embryopathy and other birlh outcomes in children of women exposed to topical tretinoin during early pregnancy. Am | Med Genel 2005; 136A: 117-21.

Martfnez-Frias ML, Rodriguez-Pinilla F.. First-trimester exposure to topical tretinoin: its safety is not warranted (Letter). Teratology 1999: 60: 5,

Maw HI). Treatment of external genital warts with 5% imiquiod cream during pregnancy: a case report. Br j Obstet Gynaecol 2004; 111: 1475.

McGready R. Hamilton KA, Simpson JA et al. Safety of the insect rcpelent n,n.-diethyl-m-loiuamide (DEET) in pregnancy. Am J Trop Med 2001: 65: 285-9.

Menter A. Pharmacokinetics and safety of tazarotene. J Am Acad Dermatol 2000; 43: 31-5,

Miller RK. Hendrickx AG, Millls |1. et al. Periconceptional vitamin A use: how much is teratogenic? Reprod Toxicol 1998; 12: 75-88

Moerike S, Pantzar JT, De Sa D. Temporal bone pathology in fetuses exposed to isotretinoin. Pedialr Dev Pathol 2002. 5: 405-9.

Mygind H. Thulstrup AM, Pedersen L et al. Risk of intrauterine growth retardation, malformations and other birth outcomes in children after topical use of corticosteroid in pregnancy. Acta Obstet Gynaecol Scand 2002: 81: 234-9.

Navarre Belhassen C. Blancehet P. Hillaire-Buys D et al. Multiple congenital malformations associated with topical tretinoin. Ann Pharmacother 1998; 32: 505-6.

Nulman I. Berkovitch M. Klein J el al. Steady-slate pharmacokinetics of isotretinoin and ist 4-oxo metabolite: implications for fetal safety. | Clin Pharmacol 1998; 38: 926-30.

Odom LI). Ploilffe ). Butler WJ. 5-fluorouracil exposure during the period of conception: a report of two cases. Am J Obstet Gynecol 1990; 163: 76-7.

Ozawa H, Azuma F., Shindo K el al. Transient renal tubular acidosis in a neonate following transplacental acelazolamide. Eur J Pediatr2001: 160: 321-2.

Robert F,, Scialli AR. Topical medications during pregnancy. Reprod Toxicol 1994; 8: 197-202.

Robertson |, Polifka JE, Avncr M et al. A survey of pregnant women using isotretinoin. Birth Def Res A 2005: 73: 881-7.

Roeleveid N, Zielhuis GA, Gahreels F. Mental retardation and parenlai occupation: a study on the applicability of job exposure matrices. Br | Indust Med 1993; 50: 945-54.

Rojansky N. Fasouliotis SJ. Ariel I et al. Extreme caudal agenesis. | Reprod Med 2002; 47; 241-5.

Schaefer C, Peters PWJ. Intrauterine diethyltoluamide exposure and fetal outcome. Reprod Toxicol 1992; 6: 175-6.

Selcen D. Seidman S, Nigro MA. Otocerebral anomalies associated with topical tretinoin use. Brain Dev 2000; 22: 218-20.

Shapiro |. Safety of topical minoxidil solution: a one-year, prospective, observational study. | Cutan Med Surg 2003; 7: 322-9.

Shapiro L, Pastuszak A, Cutro G et al. Safety of first-trimester exposure to topical tretinoin: prospective cohort study. Lancet 1997: 350: 1143-4.

Smorlesi C. Caldarella A, Caramelli L et al. Topically applied minoxidil may cause fetal malformation: a case report. Birth Def Res A 2003; 67: 997-1001.

Sparsa A. Bonnetblanc JM. Lithium. Ann Dermatol Venereol 2004; 131: 255-61.

Sudakin DL. Trevathan WK. DEET: a review and update of safely and risk in the general population. | Toxicol Clin Toxicol 2003; 41: 831-9.

Suwalsky M, Villena F. Marcus D et al. Plasma absorption and ultraslructural changes of rat testicular cells induced by lindane. Hum Exp Toxicol 2000; 19: 529-33.

Swan SH, Main KM. Liu F et al. Decrease in anogenilal distance among male infants with prenatal phthalatc exposure. Environ Health Perspcct 2005; 113; 1056-61.

Teratology Society. Recommendations for isotretinoin use in women of child bearing potential. Teratology 1991; 44: 1-6.

Van Hoogdalem EJ. Transdermal absorption of topical anti-acne agents in man; review of clinical pharmacokinetic data. J Eur Acad Dermatol Venereol 1998; 11: SI3-¡9. S28-9.

Wagenvoort AM, van Vugt )MG, Sobotka M et al. Topical timolol therapy in pregnancy: is it safe for the fetus? Teratology 1998; 58: 258-62.

Weber G, Vigone MC, Rapa A et al. Neonatal transient hypothyroidism: etiological sludy. Italian collaborative study on transient hypothyroidism. Arch Dis Childhood Fet Neonat Ed 1998; 79: F70-2.

Was this article helpful?

0 0
Acne Myths Uncovered

Acne Myths Uncovered

What is acne? Certainly, most of us know what it is, simply because we have had to experience it at one time or another in our lives. But, in case a definition is needed, here is a short one.

Get My Free Ebook


Post a comment